XNAS: NKTR
Nektar Therapeutics Live Stock Price Today, Share Analysis and Chart
about
Nektar Therapeutics is a clinical-stage, research-based biopharmaceutical company headquartered in San Francisco, California, and incorporated in Delaware, focused on discovering and developing medicines in the field of immunotherapy. The Company dir...
Read More
70.62
-3.71
(-4.99%)
1.2M
XNAS Volume
XNAS 15 May, 2026 4:03 PM (EDT)
Board Meeting
The next board meeting for Nektar Therapeutics is on 22 May 2026 for the purpose of Nektar Therapeutics Annual General Meeting for 2026
See details
Low Financial Strength
Expensive Valuation
Technically Neutral
Momentum Trap
These stocks have weak financials and expensive valuation. Medium technical scores may weaken. Investors should exercise caution
View Similar
Embed DVM
Nektar Therapeutics Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..